Abiopharma

News list

Neufeld Leah R 🟢 acquired 3.6K shares of Immuneering Corp (IMRX) at $4.29 Transaction Date: Mar 13, 2026 | Filing ID: 000044

Full text

News bot March 17, 2026, 8:47 p.m.
🔍 Neufeld Leah R (Executive)

Company: Immuneering Corp (IMRX)

Report Date: 2026-03-13
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 3,628
Detailed Transactions and Holdings:
- Acquired 3,628 shares of Class A Common Stock at $4.2925 per share (Direct)
  Date: 2026-03-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 29,598.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
Footnotes:
- F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the "ESPP"), for the ESPP purchase period of September 16, 2025 through March 15, 2026. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934.
- F2: The relevant Offering Period (as defined in the ESPP) ended on March 15, 2026. The shares were acquired on the Purchase Date (as defined in the ESPP) of March 13, 2026.
- F3: In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Purchase Date of the relevant Offering Period.